Takeda Pharmaceutical
TAK
12,40 €
Share price
0.07%
Change (1 day)
-2.14%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Cash on Hand
Cash on Hand as of March 2025 : €2.34 Billion
According to Takeda Pharmaceutical's latest financial reports the company has €2.34 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-03-31 | €2.89 B | -24.29% |
| 2023-03-31 | €3.82 B | -41.11% |
| 2022-03-31 | €6.49 B | -15.93% |
| 2021-03-31 | €7.72 B | 40.06% |
| 2020-03-31 | €5.51 B | -5.33% |
| 2019-03-31 | €5.82 B | 103.18% |
| 2018-03-31 | €2.86 B | -9.33% |
| 2017-03-31 | €3.16 B | -27.76% |
| 2016-03-31 | €4.37 B | -20.96% |
| 2015-03-31 | €5.53 B | -7.52% |
| 2014-03-31 | €5.98 B | 28.63% |
| 2013-03-31 | €4.65 B | 11.7% |
| 2012-03-31 | €4.16 B | -43.76% |
| 2011-03-31 | €7.40 B | 6.91% |
| 2010-03-31 | €6.92 B | 19.28% |
| 2009-03-31 | €5.80 B | -44.3% |
| 2008-03-31 | €10.42 B | -9% |
| 2007-03-31 | €11.45 B | -13.49% |
| 2006-03-31 | €13.24 B | 20.94% |
| 2005-03-31 | €10.95 B | 6.61% |
| 2004-03-31 | €10.27 B | 14.78% |
| 2003-03-31 | €8.95 B | 17.5% |
| 2002-03-31 | €7.61 B | 16.8% |
| 2001-03-31 | €6.52 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | €33.56 B | 1,333.41% | 🇺🇸 USA |
 Sanofi SNY | €7.48 B | 219.55% | 🇫🇷 France |
 Pfizer PFE | €14.98 B | 540.03% | 🇺🇸 USA |
 Novartis NVS | €6.22 B | 165.98% | 🇨🇭 Switzerland |
 Seagen
SGEN | €1.07 B | -54.28% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | €0.58 B | -74.96% | 🇮🇳 India |
 Amgen AMGN | €7.62 B | 225.63% | 🇺🇸 USA |
 GlaxoSmithKline GSK | €5.01 B | 114.19% | 🇬🇧 UK |
 Merck MRK | €7.98 B | 241.08% | 🇺🇸 USA |